Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | NOVO B:CPH since announced | Transaction value |
---|---|---|
Cardior Pharmaceuticals GmbH | -12.29% | 1.11bn |
Catalent Inc-Manufacturing Sites Portfolio(3) | -0.41% | -- |
Elan Drug Technologies (DNU>16Sep2011 now 01781A) | 15.84% | 92.42m |
Data delayed at least 15 minutes, as of Oct 04 2024 16:10 BST.